258 related articles for article (PubMed ID: 29966170)
21. Gastric function in diabetic gastroparesis assessed by ultrasound and scintigraphy.
Steinsvik EK; Sangnes DA; Søfteland E; Biermann M; Assmus J; Dimcevski G; Gilja OH; Hausken T
Neurogastroenterol Motil; 2022 Apr; 34(4):e14235. PubMed ID: 34378839
[TBL] [Abstract][Full Text] [Related]
22. ER stress and ER stress-induced apoptosis are activated in gastric SMCs in diabetic rats.
Chen X; Fu XS; Li CP; Zhao HX
World J Gastroenterol; 2014 Jul; 20(25):8260-7. PubMed ID: 25009401
[TBL] [Abstract][Full Text] [Related]
23. [Effect of Different Stimulating Strength of Electroacupuncture on Gastrointestinal Motility and RhoA/ROCK Signaling in Gastric Antral Smooth Muscle in Diabetic Gastroparesis Rats].
Wu XF; Chen XL; Zheng XN; Guo X; Xie ZQ; Liu L; Wei XR; Yue ZH
Zhen Ci Yan Jiu; 2018 Mar; 43(3):169-74. PubMed ID: 29560632
[TBL] [Abstract][Full Text] [Related]
24. [Effect of Electroacupuncture at "Zusanli" (ST 36), etc. on Gastrointestinal Motility and Expression of Ghrelin mRNA and Growth Hormone Secretagogue Receptor mRNA in Diabetic Gastroparesis Rats].
Lin YP; Wan QQ; Peng Y; He FE; Shen J
Zhen Ci Yan Jiu; 2015 Aug; 40(4):290-5. PubMed ID: 26502542
[TBL] [Abstract][Full Text] [Related]
25. Diabetic Gastroparesis and Nondiabetic Gastroparesis.
Shen S; Xu J; Lamm V; Vachaparambil CT; Chen H; Cai Q
Gastrointest Endosc Clin N Am; 2019 Jan; 29(1):15-25. PubMed ID: 30396524
[TBL] [Abstract][Full Text] [Related]
26. Atractylenolide‑1 alleviates gastroparesis in diabetic rats by activating the stem cell factor/c‑kit signaling pathway.
Li H; Cao W; Zhang XB; Zhang XX; Gu C; Gu LM; Pan CY; Tian YZ; Lu M
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34368880
[TBL] [Abstract][Full Text] [Related]
27. A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis.
Wang CP; Kao CH; Chen WK; Lo WY; Hsieh CL
J Altern Complement Med; 2008 Sep; 14(7):833-9. PubMed ID: 18721079
[TBL] [Abstract][Full Text] [Related]
28. [Dysmotility disorders of the stomach and possible methods of diagnosis].
Kopácová M; Bures J
Vnitr Lek; 2004 May; 50(5):344-9. PubMed ID: 15305629
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic switching in diabetic gastroparesis: mechanism directs therapy.
Owyang C
Gastroenterology; 2011 Oct; 141(4):1134-7. PubMed ID: 21875587
[No Abstract] [Full Text] [Related]
30. Ultrasonographic comparison of gastric motility between diabetic gastroparesis patients with and without metabolic syndrome.
Sogabe M; Kimura Y; Iwaki H; Okita Y; Hibino S; Sawda S; Okahisa T; Okamoto K; Tsujigami K; Hayashi H; Hukui Y; Nakamura T; Taniki T; Nakasono M; Muguruma N; Okamura S; Ito S
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e17-22. PubMed ID: 17645473
[TBL] [Abstract][Full Text] [Related]
31. Site-specific pathophysiology in a neonatal mouse model of gastroparesis.
Edwards PT; Soni KG; Conner ME; Fowler SW; Foong JPP; Stavely R; Cheng LS; Preidis GA
Neurogastroenterol Motil; 2023 Nov; 35(11):e14676. PubMed ID: 37772676
[TBL] [Abstract][Full Text] [Related]
32. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes.
Ozaki K; Monnai M; Onoma M; Muramatsu H; Yogo K; Watanabe T; Oda Y; Katagiri K; Arakawa H; Itoh Z; Omura S; Takanashi H
J Diabetes Complications; 2008; 22(5):339-47. PubMed ID: 18413164
[TBL] [Abstract][Full Text] [Related]
33. Structural changes in gastric glial cells and delayed gastric emptying as responses to early life stress and acute adulthood stress in rats.
Tominaga K; Fujikawa Y; Tanaka F; Kamata N; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y; Arakawa T
Life Sci; 2016 Mar; 148():254-9. PubMed ID: 26874028
[TBL] [Abstract][Full Text] [Related]
34. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.
Fraser RJ; Horowitz M; Maddox AF; Dent J
Gut; 1994 Feb; 35(2):172-8. PubMed ID: 8307466
[TBL] [Abstract][Full Text] [Related]
35. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
[TBL] [Abstract][Full Text] [Related]
36. Effects of AMPK on Apoptosis and Energy Metabolism of Gastric Smooth Muscle Cells in Rats with Diabetic Gastroparesis.
Zhang MH; Fang XS; Guo JY; Jin Z
Cell Biochem Biophys; 2019 Jun; 77(2):165-177. PubMed ID: 30968342
[TBL] [Abstract][Full Text] [Related]
37. Higenamine inhibits apoptosis and maintains survival of gastric smooth muscle cells in diabetic gastroparesis rat model via activating the β2-AR/PI3K/AKT pathway.
An X; Long C; Deng X; Tang A; Xie J; Chen L; Wang Z
Biomed Pharmacother; 2017 Nov; 95():1710-1717. PubMed ID: 28958133
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiology and management of gastroparesis.
Khoo J; Rayner CK; Jones KL; Horowitz M
Expert Rev Gastroenterol Hepatol; 2009 Apr; 3(2):167-81. PubMed ID: 19351287
[TBL] [Abstract][Full Text] [Related]
39. Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
Onoma M; Ozaki K; Yogo K; Monnai M; Muramatsu H; Kamei K; Kawabe Y; Hayashi S; Shiga T; Matsuo S; Suzuki M; Itoh Z; Omura S; Takanashi H
Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):788-96. PubMed ID: 18346169
[TBL] [Abstract][Full Text] [Related]
40. The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra.
Zheng LF; Song J; Fan RF; Chen CL; Ren QZ; Zhang XL; Feng XY; Zhang Y; Li LS; Zhu JX
Acta Physiol (Oxf); 2014 Jun; 211(2):434-46. PubMed ID: 24410908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
